Vector-borne diseases (VBDs) represent a significant public health challenge in India, contributing significantly to the country's disease burden. With a diverse range of vectors and climatic conditions conducive to their spread, understanding the extent of this issue is critical for healthcare professionals.
VBDs in India encompass a wide range of illnesses, including malaria, dengue, chikungunya, Japanese encephalitis, and lymphatic filariasis. Each of these diseases presents unique challenges in terms of prevention, diagnosis, and treatment, necessitating a comprehensive understanding of their epidemiology and clinical manifestations.
The epidemiology of VBDs in India is complex, influenced by factors like vector ecology, climate, and socio-economic determinants. Malaria alone accounts for a significant proportion of the disease burden, with an estimated 219 million cases globally in 2017, of which India contributed 4%. Additionally, the country reports the highest dengue burden in the world, with an estimated 100 million cases annually.
The management of VBDs in India faces numerous challenges, including inadequate surveillance, limited resources for vector control, and gaps in public awareness. However, opportunities exist in the form of advancements in diagnostic technologies, vaccine development, and integrated vector management strategies. The role of healthcare professionals is pivotal in leveraging these opportunities to mitigate the VBD burden.
Vector-borne diseases pose a significant public health challenge in India, requiring a comprehensive, multi-faceted approach. Healthcare professionals play a crucial role in this endeavor, from enhancing disease surveillance and diagnosis to driving public education efforts. By deepening our understanding of these diseases and their management, we can work towards reducing their impact on India's health landscape.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation